Since the alterations in the lipid/lipoprotein profile in LCAT-deficient carriers are involved in the pathogenesis of renal disease [17], which represents the first cause of morbidity and mortality in these subjects [18], we test the hypothesis whether the reduced LCAT concentration in CKD contributes to the progression of renal damage. Here, LCAT is linked to chronic kidney disease.